Hishani Prabaharan

Title: Hishani Prabaharan: Innovator in Anti-Thrombotic Therapy

Introduction

Hishani Prabaharan is a notable inventor based in Victoria, Australia. He has made significant contributions to the field of pharmacology, particularly in the development of anti-thrombotic therapies. With a total of two patents to his name, Prabaharan is recognized for his innovative approaches to medical treatments.

Latest Patents

Prabaharan's latest patents focus on the inhibition of phosphoinositide 3-kinase β. The present invention relates to selective inhibitors of phosphoinositide (PI) 3-kinase β, which are utilized in anti-thrombotic therapy. This invention also includes a method for screening compounds that are useful for new anti-thrombotic therapies by detecting the selective inhibitory activity of PI 3-kinase β. Additionally, the invention encompasses novel compounds that act as inhibitors of PI 3-kinase.

Career Highlights

Hishani Prabaharan is currently employed at AstraZeneca, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in drug development.

Collaborations

Prabaharan has worked alongside notable colleagues such as Shaun P. Jackson and Alan Duncan Robertson. Their collaborative efforts have further advanced the research and development of innovative therapies.

Conclusion

Hishani Prabaharan is a distinguished inventor whose work in anti-thrombotic therapy has the potential to significantly impact medical treatments. His contributions to the field, particularly through his patents, highlight his commitment to advancing healthcare solutions.